Long-term Safety and Tolerability of BHV-7000

Enrolling by invitation · Phase 2

Conditions studied: Focal Epilepsy

In brief

A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsy

Key facts

Study ID
NCT06443463
Run by
Biohaven Therapeutics Ltd.
People needed
660
Starts
2024-07-30
Expected to finish
2027-01-01
Last updated by the study team
2026-05-01

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.